Out-licensing: Pharmaceutical & Oncology/Prostate cancer

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Open Innovation for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Due Diligence; Comparison
Due Diligence: Overview; Top Applications; Online Panel Discussions; Request Consultation
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..2 of 2 - per page
Order by

Antroquinonol® is a non-toxic, highly effective cancer treatment agent, developed using natural organic chemistry. More

Novel Cancer Therapy that Simultaneously Treats Primary & Metastatic Tumors More

Displaying 1..2 of 2 - per page
Order by

Industry sector: Generics; Nutrition; OTC/Non-Prescription; Pediatric; Personal Care; Prescription
Therapeutic target: Adenocarcinoma; Benign prostatic hypertrophy
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.